R. Jyothirmayi et al., CONSERVATIVE SURGERY AND RADIOTHERAPY IN THE TREATMENT OF SPINAL-CORDASTROCYTOMA, Journal of neuro-oncology, 33(3), 1997, pp. 205-211
Spinal cord astrocytomas are rare neoplasms, and optimal treatment gui
delines are undefined. 23 patients with spinal cord astrocytomas were
treated between 1984 and 1993 with conservative surgery and postoperat
ive radiotherapy. The mean age was 31 years. Twelve patients were male
and eleven female. All patients presented with neurologic deficits. C
ervical cord was involved in five patients, cervicothoracic in four, t
horacic in eight and thoracolumbar in six. Five patients had intramedu
llary cysts. Fifteen patients had low grade tumors and six high grade.
Surgery was near total excision in three patients, partial excision i
n ten and biopsy in ten patients. All patients received postoperative
radiotherapy to a median dose of 45 Gy in 25 fractions over 5 weeks. T
he median followup was 51 months (range 7-143 months). At 6 months pos
t radiotherapy, twelve patients had improvement of neurologic status,
nine had stable status, and two deteriorated. The actuarial overall su
rvival was 55% at 5 years and 39% at 10 years. The actuarial progressi
on free survival probability was 75% at 5 years and 55% at 10 years. F
ive patients had local failure and two failed at distant sites. Twelve
patients died, six due to progressive disease, five due to complicati
ons of paraplegia and one patient of unrelated causes. Tumor grade was
a significant prognostic factor for overall survival. 5 year overall
survival was 79% for low grade tumors. No patient with high grade tumo
r survived more than 2 years and the median survival was 10 months. Lo
w grade, female sex and presence of intramedullary cysts were associat
ed with significantly improved progression free survival. Conservative
surgery followed by radiotherapy appears to have a role in achieving
tumor control and neurologic recovery in patients with low grade astro
cytomas of the spinal cord. Treatment results of high grade tumors rem
ain poor and new therapeutic strategies need to be studied.